Hexahydrodiazepinones as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Details for Australian Patent Application No. 2004261186 (hide)

Owner Merck & Co., Inc.

Inventors Feng, Danqing Dennis; Biftu, Tesfaye; Weber, Ann E.; Liang, Gui-Bai

Agent Spruson & Ferguson

Pub. Number AU-A-2004261186

PCT Pub. Number WO2005/011581

Priority 60/491,606 31.07.03 US

Filing date 27 July 2004

Wipo publication date 10 February 2005

International Classifications

C07D 243/08 (2006.01) Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/011581 Priority application(s): WO2005/011581

24 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004261187-Treatment of ocular disease

2004261185-Syringe assembly having disabling mechanism